BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29678584)

  • 1. Genome-wide profiles of metastasis-associated mRNAs and microRNAs in salivary adenoid cystic carcinoma.
    Wang S; Zhang L; Shi P; Zhang Y; Zhou H; Cao X
    Biochem Biophys Res Commun; 2018 Jun; 500(3):632-638. PubMed ID: 29678584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
    Feng X; Matsuo K; Zhang T; Hu Y; Mays AC; Browne JD; Zhou X; Sullivan CA
    Anticancer Res; 2017 Jul; 37(7):3473-3481. PubMed ID: 28668836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway.
    He Q; Zhou X; Li S; Jin Y; Chen Z; Chen D; Cai Y; Liu Z; Zhao T; Wang A
    Biochim Biophys Acta; 2013 Nov; 1830(11):5258-66. PubMed ID: 23911747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circRNA_0059655 plays a role in salivary adenoid cystic carcinoma by functioning as a sponge of miR-338-3p.
    Zhao F; Chen CW; Yang WW; Xu LH; Du ZH; Ge XY; Li SL
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):100-106. PubMed ID: 30672444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive and in-depth analysis of microRNA and mRNA expression profile in salivary adenoid cystic carcinoma.
    Han N; Lu H; Zhang Z; Ruan M; Yang W; Zhang C
    Gene; 2018 Dec; 678():349-360. PubMed ID: 30098429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.
    Sun L; Liu B; Lin Z; Yao Y; Chen Y; Li Y; Chen J; Yu D; Tang Z; Wang B; Zeng S; Fan S; Wang Y; Li Y; Song E; Li J
    Mol Cancer; 2015 Apr; 14():96. PubMed ID: 25924850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
    Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
    Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of perineural invasion in salivary adenoid cystic carcinoma by circular RNA RNF111.
    Su R; Zhong S; Wang P; Lin Z
    Clin Transl Oncol; 2023 Nov; 25(11):3152-3164. PubMed ID: 37222950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.
    Mays AC; Feng X; Browne JD; Sullivan CA
    Anticancer Res; 2016 Aug; 36(8):4013-8. PubMed ID: 27466507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.
    Kiss O; Tőkés AM; Spisák S; Szilágyi A; Lippai N; Székely B; Szász AM; Kulka J
    Pathol Oncol Res; 2015 Jan; 21(1):29-44. PubMed ID: 25240490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pivotal microRNAs involved in the development and progression of salivary adenoid cystic carcinoma.
    Zhu QH; Meng Y; Tang YT; Hou CX; Sun NN; Han W; Wang CX; Ye J
    J Oral Pathol Med; 2022 Feb; 51(2):160-171. PubMed ID: 34797582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circular RNAs differential expression profiles in the metastasis of salivary adenoid cystic carcinoma cells.
    Ju R; Huang Y; Guo Z; Han L; Ji S; Zhao L; Long J
    Mol Cell Biochem; 2021 Feb; 476(2):1269-1282. PubMed ID: 33237453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
    Yang L; Wang T; Zhang J; Wang X
    Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.
    Wang WW; Chen B; Lei CB; Liu GX; Wang YG; Yi C; Wang YY; Zhang SY
    Jpn J Clin Oncol; 2017 Aug; 47(8):690-698. PubMed ID: 28591777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR5 induces perineural invasion of salivary adenoid cystic carcinoma by inhibiting microRNA-187.
    Zhang M; Wu JS; Xian HC; Chen BJ; Wang HF; Yu XH; Pang X; Dai L; Jiang J; Liang XH; Tang YL
    Aging (Albany NY); 2021 Jun; 13(11):15384-15399. PubMed ID: 34114971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.
    Yan F; Wang C; Li T; Cai W; Sun J
    Mol Med Rep; 2018 Mar; 17(3):4237-4244. PubMed ID: 29328455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
    Xu LH; Zhao F; Yang WW; Chen CW; Du ZH; Fu M; Ge XY; Li SL
    Int J Oncol; 2019 May; 54(5):1579-1590. PubMed ID: 30896785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma.
    Wang Y; Zhang CY; Xia RH; Han J; Sun B; Sun SY; Li J
    Cell Death Dis; 2018 Sep; 9(9):917. PubMed ID: 30206227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1.
    Tang Y; Zhu Q; Yang L; Meng Y; Zhang G; Zhou T; Wang C; Song X; Su YX; Ye J
    Cell Signal; 2023 Sep; 109():110748. PubMed ID: 37290676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells.
    Wang HC; Yang Y; Xu SY; Peng J; Jiang JH; Li CY
    Oral Dis; 2015 Jul; 21(5):608-18. PubMed ID: 25684411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.